| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5572466 | Clinical Nutrition ESPEN | 2017 | 7 Pages |
Abstract
Supplementation with SMOFlipid® containing 15% fish oil during parenteral nutrition increased EPA substantially, DHA marginally, reduced AA and decreased AA to DHA ratio. It did not reduce morbidity or affect growth. Since extremely preterm infants accumulate a large deficit of DHA and AA, studies on more prolonged or different levels of DHA and AA supplementation are warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Svetlana Najm, Chatarina Löfqvist, Gunnel Hellgren, Eva Engström, Pia Lundgren, Anna-Lena HÃ¥rd, Alexandre Lapillonne, Karin Sävman, Anders K. Nilsson, Mats X. Andersson, Lois E.H. Smith, Ann Hellström,